This study demonstrates that PCV13 is immunogenic and safe in children previously vaccinated with PCV7. By eliciting high antibacterial immune responses to the additional serotypes, PCV13 provides protection against these serotypes, which are important causes of pneumococcal disease globally.
The evidence presented in the article strongly supports the notion that serotype replacement has occurred in invasive pneumococcal disease in most populations and is caused by the vaccine.
In a joint seminar by Directorate General for Health and Consumer Affairs (DG SANCO), European Food Safety Authority (EFSA) and ECDC at the European Parliament, Marc Sprenger highlighted the decrease of Salmonella infections in EU.
The seminar addressed issues such as the human cost of zoonoses, trends in food-borne diseases, challenges and lessons learnt from epidemiological investigations on the 2011 E.coli outbreak and salmonella controls.
The European Society of Intensive Care Medicine (ESICM) is organising the 24th ESICM LIVES Annual Congress in Berlin on 1-5 October 2011. This congress is one of the major meetings, gathering numerous well-known international experts in the field of intensive care medicine.
Location:Berlin
Organized by:European Society of Intensive Care Medicine
In an editorial in the scientific journal Eurosurveillance, ECDC noted that, based on numerous studies, paediatricians, family practitioners and nurses form the backbone of each national immunisation programme in the EU.
Clostridium difficile infection is the leading cause of healthcare-associated diarrhoea in the developed world and represents a major financial burden for European healthcare systems.
Clostridium difficile infection (CDI) is an intestinal infection usually acquired in hospital settings, after antibiotic treatment. The clinical spectrum of CDI ranges from mild diarrhoea to severe life-threatening pseudomembranous colitis. In the recent years, an increased incidence of CDI has been reported in Europe and worldwide.
The authors describe the epidemiology of invasive Hib and nontype b H. influenzae infections in children <15 years of age in the United Kingdom from 1994 until 2008, and show that the resurgence in Hib disease during the years 1999-2003 did not affect the epidemiology of invasive nontype b H. influenzae disease in children, which provides further support against serotype replacement.